3D Vena Contracta Area After MitraClip© Procedure: Precise Quantification of Residual Mitral Regurgitation and Identification of Prognostic Information
Overview
Radiology
Authors
Affiliations
Background: Percutaneous mitral valve repair (PMVR) is increasingly performed in patients with severe mitral regurgitation (MR). Post-procedural MR grading is challenging and an unsettled issue. We hypothesised that the direct planimetry of vena contracta area (VCA) by 3D-transoesophageal echocardiography allows quantifying post-procedural MR and implies further prognostic relevance missed by the usual ordinal scale (grade I-IV).
Methods: Based on a single-centre PMVR registry containing 102 patients, the association of VCA reduction and patients' functional capacity measured as six-minute walk distance (6 MW) was evaluated. 3D-colour-Doppler datasets were available before, during and 4 weeks after PMVR.
Results: Twenty nine patients (age 77.0 ± 5.8 years) with advanced heart failure (75.9% NYHA III/IV) and severe degenerative (34%) or functional (66%) MR were eligible. VCA was reduced in all patients by PMVR (0.99 ± 0.46 cm vs. 0.22 ± 0.15 cm, p < 0.0001). It remained stable after median time of 33 days (p = 0.999). 6 MW improved after the procedure (257.5 ± 82.5 m vs. 295.7 ± 96.3 m, p < 0.01). Patients with a decrease in VCA less than the median VCA reduction showed a more distinct improvement in 6 MW than patients with better technical result (p < 0.05). This paradoxical finding was driven by inferior results in very large functional MR.
Conclusions: VCA improves the evaluation of small residual MR. Its post-procedural values remain stable during a short-term follow-up and imply prognostic information for the patients' physical improvement. VCA might contribute to a more substantiated estimation of treatment success in the heterogeneous functional MR group.
Rottlander D, Hausleiter J, Schmitz T, Bufe A, Seyfarth M, von Bardeleben R Clin Res Cardiol. 2024; .
PMID: 39652118 DOI: 10.1007/s00392-024-02580-6.
Scalia I, Farina J, Wraith R, Brown L, Abbas M, Pereyra M Heliyon. 2024; 10(11):e32378.
PMID: 38933987 PMC: 11200332. DOI: 10.1016/j.heliyon.2024.e32378.
3D echocardiography in mitral valve prolapse.
Mantegazza V, Gripari P, Tamborini G, Muratori M, Fusini L, Ali S Front Cardiovasc Med. 2023; 9:1050476.
PMID: 36704460 PMC: 9871497. DOI: 10.3389/fcvm.2022.1050476.
Pozo Osinalde E, Salinas Gallegos A, Gordillo X, Nombela Franco L, Marcos-Alberca P, Mahia P J Clin Med. 2022; 11(9).
PMID: 35566402 PMC: 9102104. DOI: 10.3390/jcm11092276.
Sudarsky D, Kusniec F, Grosman-Rimon L, Lubovich A, Kinany W, Hazanov E J Clin Med. 2021; 10(22).
PMID: 34830731 PMC: 8624366. DOI: 10.3390/jcm10225448.